Particle Therapy Market Significant Size & Share Growth in Global by 2024 – ZMR Blog
Trending News & Updates

Particle Therapy Market Significant Size & Share Growth in Global by 2024

Zion Market Research has published a new report titled “Particle Therapy Market by Type (Heavy Ion Therapy and Proton Therapy), by System (Single-Room and Multi-Room), by Product (Cyclotrons, Synchrocyclotrons, and Synchrotrons), by Cancer Type (Pediatric Cancer, Breast Cancer, Prostate Cancer, Head and Neck Cancer, Lung Cancer, and Others), and by Application (Research Applications and Treatment Applications): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024”. According to the report, the global particle therapy market was valued at approximately USD 770 million in 2017 and is expected to generate around USD 1439 million by 2024, at a CAGR of around 9.5% between 2018 and 2024.

Particle therapy uses rays of charged positive ions, neutrons, or protons for cancer treatment. Particle therapy is a revolutionary domain of external beam radiotherapy, which combines research in physics and its application in the field of oncology. It has the potential to cure some short and long-term complications. The non-invasive characteristic of particle therapy is a major advantage that can result in more patients receiving the treatment. Carbon ion beams are most often used for treating cancer. Proton therapy is the most popular type of particle therapy. It uses proton beams to irradiate affected tissue. Proton therapy employs ionizing radiation. A particle accelerator is used in proton therapy to aim tumors with proton beams.

Request Brochure of Particle Therapy Market Report for more Industry Insights @

Increasing incidences of cancer, rising use of particle therapy in clinical trials, multiple advantages of particle therapy, the growing number of particle therapy hubs globally, increasing usage of tobacco in some regions, rising per capita healthcare expenditure, and increasing geriatric population are likely to be the growth drivers of the global particle therapy market. Rising worldwide awareness regarding particle therapy and increasing investments by major players are likely to create new growth opportunities for the market players. However, challenges faced by the healthcare sector regarding infrastructure, accessibility, affordability of treatments, restricted insurance cover for particle therapy, and unfavorable reimbursement policies might restrict the particle therapy market globally in the future.

Global Particle Therapy Market.

The global particle therapy market is segmented based on type, system, product, cancer type, and application. By type, this market includes heavy ion therapy and proton therapy. By system, the market includes single-room and multi-room systems. By product, the market includes cyclotrons, synchrocyclotrons, and synchrotrons. By cancer type, this market includes pediatric cancer, breast cancer, prostate cancer, head and neck cancer, lung cancer, and others. By application, this market includes research applications and treatment applications.

By region, this global market includes North America, Latin America, Europe, the Middle East, and Africa, and the Asia Pacific. The Asia Pacific region is likely to lead this global market in the future, owing to the growing healthcare expenditure, a rising number of initiatives for the promotion of latest particle therapy usage, and increasing incidences of cancer. North America is likely to be the second largest particle therapy market in the upcoming years, due to technological advancements related to particle therapy, availability of advanced treatment, adoption of latest diagnostic technologies, and high per capita healthcare expenditure. The European particle therapy market is anticipated to grow rapidly over the estimated timeframe, owing to the availability of the latest healthcare infrastructure and growing cancer prevalence in the region.

Get Sample of Particle Therapy Market Report for more Industry Insights @

Some key players of the particle therapy market include Varian Medical Systems, Inc., Ion Beam Applications SA, Hitachi, Ltd., Mevion Medical Systems, Inc., Provision Healthcare, Sumitomo Heavy Industries, Ltd., ProTom International, Inc., Optivus Proton Therapy, Inc., Danfysik A/S, and Advanced Oncotherapy Plc, among others.

This report segments the global particle therapy market into:

Global Particle Therapy Market: By Type

  • Heavy Ion Therapy
  • Proton Therapy

Global Particle Therapy Market: By System

  • Single-Room Systems
  • Multi-Room Systems

Global Particle Therapy Market: By Product

  • Cyclotrons
  • Synchrocyclotrons
  • Synchrotrons

Global Particle Therapy Market: By Cancer Type

  • Pediatric Cancer
  • Breast Cancer
  • Prostate Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Others

Global Particle Therapy Market: By Application

  • Research Applications
  • Treatment Applications

Inquiry more about this report @

Global Particle Therapy Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Leave A Reply

Your email address will not be published.